Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 - Ari Hakimi, TCGA Scientific Symposium 2012
You will need Adobe Flash Player 8 or later and JavaScript enabled to view this video.
Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 - Ari Hakimi, TCGA Scientific Symposium 2012
>> View All Videos
